Endoscopic Suturing System for Tissue Apposition
Evaluation of an Endoscopic Suturing System for Tissue Apposition
1 other identifier
interventional
9
1 country
1
Brief Summary
The objective of this feasibility trial is to evaluate the Ethicon Endo-Surgery Endoscopic Suturing System (ESS) for tissue apposition and reduction of the size of a dilated GJ anastomosis in subjects who are regaining weight after successful weight loss following gastric bypass. Post-procedure weight will be followed to assess whether weight loss is resumed. The ESS is an FDA-cleared (510(k)) sterile, single-use, disposable suturing system indicated for endoscopic placement of suture(s) and approximation of soft tissues. It is designed to facilitate endoscopic gastrointestinal procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable obesity
Started Feb 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2007
CompletedFirst Submitted
Initial submission to the registry
June 29, 2007
CompletedFirst Posted
Study publicly available on registry
July 3, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2008
CompletedResults Posted
Study results publicly available
August 11, 2009
CompletedSeptember 10, 2009
September 1, 2009
1.2 years
June 29, 2007
April 21, 2009
September 8, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Knotting Elements Placed
completion of plication (1-3 knotting elements placed per procedure)
intra-operative
Study Arms (1)
Tissue plication
EXPERIMENTALThe Endoscopic Suturing System (ESS) is used for tissue apposition and reduction of the size of a dilated GJ anastomosis in subjects who are regaining weight after successful weight loss following gastric bypass
Interventions
Tissue apposition and plication of a dilated GJ anastomosis with the Endoscopic Suturing System
Eligibility Criteria
You may qualify if:
- Subjects must fulfill the following criteria to be entered in this study:
- Review and sign informed consent;
- Between 21 and 65 years of age (inclusive) at time of trial enrollment;
- Documented Roux-en-Y Gastric Bypass (RYGB) surgery date
- Documented baseline weight at the time of RYGB procedure;
- \> 12 months post RYGB);
- Body mass Index (BMI) \> 30 and at least 20 pounds in excess of post-RYGB weight nadir;
- Patients initially achieved at least 50% excess weight loss (EWL) post RYGB;
- Visible anastomotic junction (between gastric pouch and the Roux-limb);
- Stoma size at screening \> 15mm; and
- Negative serum pregnancy test for women of childbearing potential.
You may not qualify if:
- Subjects will be excluded from the trial for any of the following:
- Documented history of esophageal pathology (e.g., esophageal varices, Barrett's Esophagus);
- American Anesthesia Association (ASA) Class IV or V and/or any contraindications to monitored anesthesia;
- Documented history of GJ anastomosis stricture (within 6 months);
- Documented history of previous RYGB revision;
- Presence or documented presence of gastric/duodenal ulcers;
- Presence of sepsis;
- Medical or physical endoscopic contraindications, including esophageal varices or bleeding, laryngeal perforation, trauma to pharynx, aspiration pneumonia, acute peritonitis, and other conditions where general endoscopic techniques and/or placement of overtube are contraindicated;
- Chronic Non-Steroidal Anti-Inflammatory Drug (NSAID) use (subjects taking a single aspirin tablet per day for cardioprotection are considered acceptable);
- Uncontrolled diabetes;
- Physical or psychological condition which would impair trial participation per investigator discretion;
- Binge-eating or similar eating disorders;
- Unable or unwilling to attend follow-up visits and examinations;
- Participation in any other investigational device or drug trial within 30 days prior to enrollment; or
- Any condition, which precludes compliance with the trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Susan Knippenberg
- Organization
- Ethicon Endo-Surgery
Study Officials
- PRINCIPAL INVESTIGATOR
Alfonso Torquati, MD
Vanderbilt University Medical Center
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
June 29, 2007
First Posted
July 3, 2007
Study Start
February 1, 2007
Primary Completion
April 1, 2008
Study Completion
June 1, 2008
Last Updated
September 10, 2009
Results First Posted
August 11, 2009
Record last verified: 2009-09